3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
60
Neoplasms
58
Lung Neoplasms
32
Prostatic Neoplasms
24
Colorectal Neoplasms
24
Carcinoma, Non-Small-Cell Lung
21
Neoplastic Cells, Circulating
20
Head and Neck Neoplasms
19
Pancreatic Neoplasms
17
Melanoma
14
Ovarian Neoplasms
13
Carcinoma, Hepatocellular
12
Esophageal Neoplasms
10
Colonic Neoplasms
10
Uterine Cervical Neoplasms
9
Liver Neoplasms
9
Glioma
9
Squamous Cell Carcinoma of Head and Neck
8
Multiple Myeloma
8
Leukemia, Myeloid, Acute
8
Sarcoma
7
Neoplasm Metastasis
7
Endometrial Neoplasms
7
Stomach Neoplasms
6
Neoplasm, Residual
6
Myeloproliferative Disorders
6
Leukemia
6
Kidney Neoplasms
6
Gastrointestinal Neoplasms
6
Carcinoma, Renal Cell
6
Interventions
Neoadjuvant Therapy
2
Proctectomy
1
Positron Emission Tomography Computed Tomography
1
Patient Reported Outcome Measures
1
Observation
1
Magnetic Resonance Imaging
1
Independent Medical Evaluation
1
Immunohistochemistry
1
Immune Checkpoint Inhibitors
1
Endoscopy
1
Dynamic Contrast Enhanced Magnetic Resonance Imaging
1
Diffusion Magnetic Resonance Imaging
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Pathologic Complete Response
×
Blood Specimen Collection
×
Clear all
NCT03474341
2020-11-16
PRIDE
UMC Utrecht
Unknown
200 enrolled